Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
18189 | 500 | 52.9 | 87% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
168 | 21544 | ASYMMETRIC DIMETHYLARGININE//ENDOTHELIUM//ADMA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | VASCULAR AGING | Author keyword | 3 | 20% | 3% | 13 |
2 | REYNOLDS OKLAHOMA AGING | Address | 3 | 14% | 4% | 18 |
3 | ENDOTHELIUM DEPENDENT DILATION | Author keyword | 2 | 18% | 2% | 8 |
4 | ARTERIAL AGING | Author keyword | 2 | 26% | 1% | 5 |
5 | CELLS VASCULAR SMOOTH MUSCLE | Author keyword | 1 | 50% | 0% | 2 |
6 | MYOCARDIAL MICROVASCULAR ENDOTHELIAL CELLS | Author keyword | 1 | 50% | 0% | 2 |
7 | PEGGY CHARLES STEPHENSON CANC | Address | 1 | 16% | 1% | 6 |
8 | AGING INFLAMMAT | Address | 1 | 40% | 0% | 2 |
9 | GP91DS TAT | Author keyword | 1 | 33% | 0% | 2 |
10 | VASCULAR AGEING | Author keyword | 1 | 17% | 1% | 4 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MAJOR SHAREHOLDERS | 7 | 20% | 7% | 33 |
2 | CARDIOVASCULAR DISEASE ENTERPRISES | 7 | 18% | 7% | 34 |
3 | LEWIS DWARF RATS | 5 | 63% | 1% | 5 |
4 | PRIMATE MACACA MULATTA | 4 | 39% | 2% | 9 |
5 | PGHS 2 DEPENDENT VASOCONSTRICTION | 4 | 75% | 1% | 3 |
6 | SKELETAL MUSCLE ARTERIOLES | 3 | 12% | 5% | 24 |
7 | ELASTIC ARTERY COMPLIANCE | 3 | 50% | 1% | 4 |
8 | SUBCLINICAL ARTERIAL DISEASE | 3 | 50% | 1% | 4 |
9 | VASCULAR ENDOTHELIAL DYSFUNCTION | 3 | 16% | 3% | 14 |
10 | AGING ARTERIES | 1 | 100% | 0% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Proinflammation: the key to arterial aging | 2014 | 12 | 68 | 46% |
Inflammation and endothelial dysfunction during aging: role of NF-kappa B | 2008 | 157 | 107 | 28% |
Oxidative stress and vascular inflammation in aging | 2013 | 42 | 333 | 25% |
Aging and vascular endothelial function in humans | 2011 | 79 | 174 | 30% |
Mechanisms of Vascular Aging: New Perspectives | 2010 | 132 | 179 | 23% |
Arterial aging: a journey into subclinical arterial disease | 2010 | 53 | 55 | 44% |
Endothelial dysfunction and aging: An update | 2010 | 60 | 139 | 34% |
Vascular biology of ageing-Implications in hypertension | 2015 | 2 | 134 | 20% |
Mechanisms involved in the aging-induced vascular dysfunction | 2012 | 39 | 171 | 29% |
Endothelial aging | 2005 | 238 | 127 | 19% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | REYNOLDS OKLAHOMA AGING | 3 | 14% | 3.6% | 18 |
2 | PEGGY CHARLES STEPHENSON CANC | 1 | 16% | 1.2% | 6 |
3 | AGING INFLAMMAT | 1 | 40% | 0.4% | 2 |
4 | BHP GLASGOW CARDIOVASC | 1 | 50% | 0.2% | 1 |
5 | CNRS 7213 | 1 | 50% | 0.2% | 1 |
6 | DPT FARMACOL TER EUT TOXICOL | 1 | 50% | 0.2% | 1 |
7 | FARMAKOLOGIJO EKSPERIMENTALNO TOKSIKOLOGIJ | 1 | 50% | 0.2% | 1 |
8 | GEN URGERY | 1 | 50% | 0.2% | 1 |
9 | HOSP LONGYAN 1 | 1 | 50% | 0.2% | 1 |
10 | HYPERTENS UNIT BASIC BIOMED SCI | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000155677 | ENDOTHELIUM DEPENDENT CONTRACTIONS//ENDOTHELIUM DEPENDENT CONTRACTION//ENDOTHELIUM DERIVED CONTRACTING FACTOR |
2 | 0.0000144466 | INTERVAL SPRINT TRAINING//DIABET CARDIOVASC HLTH//DIABET CARDIOVASC BIOL PROGRAM |
3 | 0.0000134954 | CORONARY ARTERY NARROWING//VENTRICULAR FAILURE//BALKE BIODYNAM |
4 | 0.0000124770 | ROCKIES FDN//EXERCISE HYPEREMIA//HUMAN CARDIOVASC PHYSIOL |
5 | 0.0000106760 | CAROTID GLOMUS//GUANADREL//CATECHOLAMINERGIC LESIONS |
6 | 0.0000095684 | FLOW MEDIATED DILATION//FLOW MEDIATED DILATATION//ENDOTHELIAL FUNCTION |
7 | 0.0000095383 | UMR 6214//C3HEB FEJ//IFR CIRCULAT PARIS NORD |
8 | 0.0000072512 | VASCULAR ENDOTHELIAL DYSFUNCTION//MOL CARDIOBIOL PROGRAM//VASCULAR ENDOTHELIUM DYSFUNCTION |
9 | 0.0000068884 | NADPH OXIDASE//NOX1//NOX4 |
10 | 0.0000066378 | P66SHC//SHC//SHC FAMILY |